No internet connection — showing the saved version of the page.

BIOMERIEUX

FREUR
← to the screener

BIOMERIEUX (US:BMXMF) — Diagnostics & Research. Number of exchanges where the company shares trade: 4. On this page — price and chart, dividends, top holders and share count history.

About the company

Website
biomerieux.fr
Sector
Healthcare · Diagnostics & Research
Headquarters
Marcy-l'Étoile, France
CEO
Pierre Boulud
Employees
14 562
Founded
1963
Shares outstanding
117.95 M
Free float
40.02 M
Market cap
9.17 B EUR
Insiders
66.46%
Institutions
16.73%
Legal form
K65D
ISIN
FR0013280286
LEI
549300AK8Y0LBIQ4T071
Payout ratio
24.9%
FCF
586 M EUR
Payout / FCF
20%
Debt
422 M EUR
0.0 y of FCF
Dividend streak
21 y
Earnings, FCF and dividends paid — for the 12 months to 30.06.2026 (the company's latest report).
Description

bioMérieux S.A. develops, manufactures, and markets in vitro diagnostic solutions for infectious diseases in France, Europe, Africa, the Middle East, North and South America, the Asia Pacific, and internationally. It operates through Clinical Applications and Industrial Applications segments. The company offers CHROMID RANGE, a chromogen culture media; air, surface, and water monitoring systems; BACT/ALERT VIRTUO, a blood sample culture system; BIOFIRE, a multiplex polymerase chain reaction system (PCR); BIOFIRE SPOTFIRE, a lowplex PCR point-of-care system; VITEK MS, a mass spectrometry system; VITEK 2, an automated identification and antimicrobial susceptibility testing (AST) system; API RANGE standardized ID strips; VITEK REVEAL, a rapid AST system; ETEST, a gradient method on culture media; BIOMERIEUX EPISEQ CS, a whole genome sequencing solution for epidemiologic monitoring; VIDAS, a specific marker of severe bacterial infections/sepsis; and Biomérieux vision suite, a software that provides information to support diagnosis and clinical decision making. It also provides culture media and associated instruments; ARGENE that provides PCR tests for diagnosing viral respiratory diseases; EMAG system and NUCLISENS extraction reagents for DNA and RNA extraction; GENE-UP and VERIFLOW for detection of microorganisms for the food industry; ETEST for manual measurement of minimum inhibitory concentration of an antibiotic; API and RAPIDEC CARBA NP for identification of bacteria and manual antimicrobial susceptibility testing; BIOBALL for quantitative microbiological quality control; CHEMUNEX, a microbiology instrument; ENDONEXT for detection of endotoxins; TEMPO for fluorescence counting of bacteria; and Hybiome, a CLIA technology, as well as lab consultancy service and training modules. The company was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. operates as a subsidiary of Institut Mérieux SA.

advertisement

Exchanges and tickers

ExchangeTickerCurrencyPriceType
PA Euronext ParisBIM primaryEUR85.9 +0.59%common stock
LSE London Stock Exchange0RUG IOBEUR104.4 +0.00%common stock
US USA StocksBMXMF OTCUSD95 +4.00%common stock
VI Vienna Stock ExchangeBIM secondaryEUR81 +1.44%common stock

Price for 3 months

up day down day dividend ex-date payment dateHover / tap a day — open, close, high and low prices

Dividends

Per year, US:BMXMF: 0.98 EUR (1 paym.)

BIOMERIEUX (BMXMF) pays dividends once a year. Per year (12 months up to and including the latest announced payment): 0.98 EUR per share (payments: 1). Based on payment history, the next ex-dividend date is expected around 10.06.2027. Uninterrupted dividend history: 21 years.

Ex-datePaymentAmount%TypeTicker
2026-06-102026-06-110.9800 EUR1.3/1.3 %annualUS:BMXMF
2025-06-102025-06-110.9000 EUR0.7/0.7 %annualUS:BMXMF
2024-06-102024-06-110.8500 EUR0.9/0.9 %annualUS:BMXMF

Top holders

HolderStakeSharesReport date
New Economy Fund0.86%1.02 M2026-06-30
VANGUARD STAR FUNDS-Vang…0.54%638 3802026-04-30
Tweedy, Browne Fund Inc.…0.41%481 7312026-06-30
VANGUARD TAX-MANAGED FUN…0.32%384 5602026-06-30
iShares Trust-iShares Co…0.26%304 3802026-07-31
AMERICAN FUNDS INSURANCE…0.19%226 5732026-06-30
Fidelity Concord Street…0.13%149 0192026-07-31
Bridge Builder Trust-Bri…0.12%142 4212026-06-30
iShares Trust-iShares MS…0.12%142 2442026-07-31
DFA INVESTMENT TRUST CO-…0.09%109 8292026-04-30
Pacer Advisors, Inc.0%2022026-06-30